Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19129975rdf:typepubmed:Citationlld:pubmed
pubmed-article:19129975lifeskim:mentionsumls-concept:C0029921lld:lifeskim
pubmed-article:19129975lifeskim:mentionsumls-concept:C0019994lld:lifeskim
pubmed-article:19129975lifeskim:mentionsumls-concept:C0003250lld:lifeskim
pubmed-article:19129975lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:19129975lifeskim:mentionsumls-concept:C1704775lld:lifeskim
pubmed-article:19129975lifeskim:mentionsumls-concept:C0679722lld:lifeskim
pubmed-article:19129975lifeskim:mentionsumls-concept:C1705938lld:lifeskim
pubmed-article:19129975lifeskim:mentionsumls-concept:C1527178lld:lifeskim
pubmed-article:19129975pubmed:issue4lld:pubmed
pubmed-article:19129975pubmed:dateCreated2011-4-5lld:pubmed
pubmed-article:19129975pubmed:abstractTextInfliximab, a chimeric monoclonal antibody to tumour necrosis factor alpha, is administered as an intravenous infusion requiring a costly hospital day case or inpatient admission.lld:pubmed
pubmed-article:19129975pubmed:languageenglld:pubmed
pubmed-article:19129975pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19129975pubmed:citationSubsetIMlld:pubmed
pubmed-article:19129975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19129975pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19129975pubmed:statusMEDLINElld:pubmed
pubmed-article:19129975pubmed:monthDeclld:pubmed
pubmed-article:19129975pubmed:issn1863-4362lld:pubmed
pubmed-article:19129975pubmed:authorpubmed-author:FitzGeraldOOlld:pubmed
pubmed-article:19129975pubmed:authorpubmed-author:BresnihanBBlld:pubmed
pubmed-article:19129975pubmed:authorpubmed-author:VealeD JDJlld:pubmed
pubmed-article:19129975pubmed:authorpubmed-author:CallananIIlld:pubmed
pubmed-article:19129975pubmed:authorpubmed-author:AlraqiSSlld:pubmed
pubmed-article:19129975pubmed:authorpubmed-author:DoranJ-PJPlld:pubmed
pubmed-article:19129975pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19129975pubmed:volume178lld:pubmed
pubmed-article:19129975pubmed:ownerNLMlld:pubmed
pubmed-article:19129975pubmed:authorsCompleteYlld:pubmed
pubmed-article:19129975pubmed:pagination497-501lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:meshHeadingpubmed-meshheading:19129975...lld:pubmed
pubmed-article:19129975pubmed:year2009lld:pubmed
pubmed-article:19129975pubmed:articleTitleAn audit of hospital based outpatient infusions and a pilot program of community-based monoclonal antibody infusions.lld:pubmed
pubmed-article:19129975pubmed:affiliationDepartment of Rheumatology, St Vincent’s University Hospital, Dublin, Ireland. johnpauldoran@gmail.comlld:pubmed
pubmed-article:19129975pubmed:publicationTypeJournal Articlelld:pubmed